Sun Pharmaceutical Industries Ltd.

factsheet Factsheet
  • Value Research Rating market-capitalisation-info
    3 star
  • Market Capitalisation market-capitalisation-info ₹3,72,437 Cr
  • Price to Earnings Ratio price-to-earning 41.82
  • 12 Month Earnings monthly-earning ₹8,906 Cr

Introducing Stock Ratings

Value Research Rating
3 star
Quality Score fund-quick-summary-circle
7/10
Growth Score fund-quick-summary-circle
6/10
Valuation Score fund-quick-summary-circle
4/10

Sun Pharmaceutical Industries Ltd. Share Price

₹1,552.10

As on 04-Mar-2024 IST

up-down-arrow1.550.10%

  • Prev Close info

    1,550.55

  • Day's Openinfo

    1,550.55

  • Today's Highinfo

    1,569.10

  • Today's Lowinfo

    1,548.90

  • Today's Volumeinfo

    22,98,105

  • 52 Week rangeinfo

    ₹922.45 - 1,587.80

Please wait...

Sun Pharmaceutical Industries Ltd. Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Sun Pharmaceutical
23.24 9.56 26.06 60.52 35.47 28.25 9.52
S&P BSE Sensex
2.26 2.48 9.47 23.51 12.82 15.42 13.43
S&P BSE Healthcare
10.16 2.87 14.03 60.22 17.25 20.14 12.53
As on 04-Mar-2024
2023
2022
2021
2020
2019
2018
2017
Sun Pharmaceutical
25.77 18.41 41.84 36.39 -0.23 -25.01 -9.34
S&P BSE Sensex
18.74 4.44 21.99 15.75 14.38 5.87 27.91
S&P BSE Healthcare
36.97 -12.10 20.87 61.45 -3.55 -5.89 0.49

Valuation Score

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Sun Pharmaceutical Industries Ltd. Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Sun Pharmaceutical Industries Ltd.

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis of Sun Pharmaceutical Industries Ltd.

        Other details of Sun Pharmaceutical Industries Ltd.

        Incorporated

        1993

        Chairman

        --

        Managing Director

        Dilip S Shanghvi

        Group

        Sun Pharma

        Headquarters

        Vadodara, Gujarat

        FAQs for Sun Pharmaceutical Industries Ltd.

        The total asset value of Sun Pharmaceutical Industries Ltd. stood at ₹ 79,441 Cr as on 31-Dec-23

        The share price of Sun Pharmaceutical Industries Ltd. is ₹1,552.10 (NSE) and ₹1,552.25 (BSE) as of 04-Mar-2024 IST. Sun Pharmaceutical Industries Ltd. has given a return of 35.47% in the last 3 years.

        Sun Pharmaceutical Industries Ltd. has a market capitalisation of ₹ 3,72,437 Cr as on 04-Mar-2024. As per Value Research classification, it is a Large Cap company.

        The P/B ratio of Sun Pharmaceutical Industries Ltd. is 5.97 times as on 04-Mar-2024, a 0.5% premium to its peers’ median range of 3.99 times.

        The P/E ratio of Sun Pharmaceutical Industries Ltd. is 41.82 times as on 04-Mar-2024, a -0.03% premium to its peers’ median range of 43.30 times.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Sun Pharmaceutical Industries Ltd. and enter the required number of quantities and click on buy to purchase the shares of Sun Pharmaceutical Industries Ltd..

        Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and anti retro viral medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.

        The promoters of Sun Pharmaceutical Industries Ltd. are Shanghvi Finance Private Limited and Dilip Shantilal Shanghvi. They collectively own 49.9 per cent of the total equity. The chairman of the company is

        The promoters of Sun Pharmaceutical Industries Ltd. have pledged 1.33% of the total equity as on Dec-23.

        Sun Pharmaceutical Industries Ltd. Ratios
        Return on equity(%)
        16.2
        Return on capital employed(%)
        --
        Debt-to-equity ratio
        0
        Dividend yield(%)
        0.74

        Yes, TTM profit after tax of Sun Pharmaceutical Industries Ltd. was ₹8,906 Cr.

        Edit peer-selector-edit
        Please wait...
        Please wait...
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information ₹3,72,436.77 Cr
        • Revenue (TTM)revenue-information ₹47,444.62 Cr
        • Earnings (TTM) earning-information ₹8,906.27 Cr
        • Cash date-information ₹14,833.25 Cr
        • Total Debt info ₹6,197.88 Cr
        • Promoters' ownership promoters_ownership 54.48%
        • Liquidity liquidity High
        • 52 Week range week-range ₹922.45 - 1,587.80
        • Face value face-value ₹1.00
        • Shares outstanding share-outstanding 2,39,93,34,970
        • 10 Years Aggregate:

          CFO: ₹56,115.62 Cr

          EBITDA: ₹81,282.58 Cr

          Net Profit: ₹47,075.76 Cr

        About The Company

        • Incorporated 1993
        • Chairman --
        • Managing Director Dilip S Shanghvi
        • Group Sun Pharma
        • Listing key-listing BSE: 524715, NSE: SUNPHARMA
        • Country India
        • Headquarters headquarters Vadodara, Gujarat
        • Website website www.sunpharma.com
        • Business

          Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations...  in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and anti retro viral medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.  Read more